Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Hepatitis C × Infliximab × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other neoplasm 1 Dermatologic 1

Conditions

Precancerous Conditions 1 Melanoma 1 Inflammatory Bowel Diseases 1 Hepatitis C 1 Hematologic Neoplasms 1 Granulomatous Disease, Chronic 1 Crohn Disease 1

Interventions

Ribavirin 3 tremelimumab 1 telaprevir 1 peginterferon alfa-2a 1 ledipasvir, sofosbuvir drug combination 1 Sofosbuvir 1 Infliximab 1 Hypothermia, Induced 1 Chromatography, High Pressure Liquid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00897312 2016-04-25

Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease

Vanderbilt-Ingram Cancer Center

DermatologicOther neoplasm

Hepatitis C, Melanoma, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon ⚡